Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X
Scientific presentation

In pursuit of the leukemic stem cell: Leveraging single-cell genomics and proteomics to identify drivers of AML


Katherine D Cummins, MD FRACP FRCPA
AMP (2019)
Description

Single-cell sequencing methods have improved our ability to better characterize tumor heterogeneity. However, current modalities are unable to determine both genotype and phenotype simultaneously from the same cell. Dr. Katherine Cummins, from the University of Pennsylvania, is a hematological pathologist focused on treating patients with AML. Current diagnostic methods rely on the presence or absence of MRD using the gold standards of multiparameter flow cytometry, RT-qPCR, and NGS. However, none of these methods provide a holistic view to monitor patients and guide treatment paths. By utilizing single-cell analysis her lab is able to determine the best cell therapies for patients and offer a more targeted approach to treatments.



VIEW


Scientific presentation
Get SNVs and CNVs from the Tapestri Platform
Kelly Kaihara, PhD
Robert Durruthy-Durruthy, PhD
Nature Research (2019)
Scientific presentation
Investigation of AML clonal architecture with mutational and immunophenotypic profiling simultaneously from the same cell(s)
Linde Miles, PhD
AMP (2019)
Scientific presentation
Single-cell sequencing reveals clonal heterogeneity in acute lymphoblastic leukemia
Jan Cools, PhD
Llucia Albert Servera, PhD
Genome Web (2019)
Scientific presentation
Unravelling clonal heterogeneity and evolutionary history of AML by single-cell DNA sequencing
Koichi Takahashi, MD
AACR (2019)
REQUEST QUOTE